Related Experiment Video
Updated: Sep 18, 2025

23:33
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
83.9K
Redo minimally invasive LAA closure with WATCHMAN device
Maris Bartkevics1, Fabio Pregaldini1, Lorenz Räber2
1Department of Cardiac Surgery, Inselspital, Bern University Hospital, Switzerland.
Multimedia Manual of Cardiothoracic Surgery : MMCTS
|June 24, 2025
Summary
This tutorial shows minimally invasive left atrial appendage (LAA) closure using the WATCHMAN device when standard methods fail. It offers an alternative for patients with prior heart surgery history.
Area of Science:
- Cardiology
- Medical Devices
- Minimally Invasive Surgery
Background:
- Left atrial appendage (LAA) closure is crucial for preventing stroke in patients with atrial fibrillation.
- Anticoagulation therapy is the standard treatment but can fail or be contraindicated.
- Prior cardiac surgery can complicate standard LAA closure procedures.
Purpose of the Study:
- To demonstrate the feasibility of using the WATCHMAN device for LAA closure in a patient with a history of cardiac surgery.
- To provide an alternative LAA closure method when standard devices are not suitable.
Main Methods:
- Video demonstration of a transcatheter-based implantation of the FDA- and EMA-approved WATCHMAN device.
- Procedure performed in a patient with prior heart surgery where AtriClip device implantation was not feasible.
Main Results:
- Successful implantation of the WATCHMAN device for LAA closure.
- Demonstration of a viable alternative to surgical LAA closure in complex cases.
Conclusions:
- The WATCHMAN device offers a safe and effective alternative for LAA closure in patients with prior cardiac surgery.
- Minimally invasive LAA closure with WATCHMAN can be considered when standard approaches are contraindicated or technically challenging.
Related Concept Videos
Mitral Regurgitation III: Medical Management
35
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
35
Mitral Stenosis III: Medical Management
29
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
29

